Mount Airy Medicaid payments for non-oral drug administration totaled $16,750 in 2024

In 2024, Medicaid providers in Mount Airy billed $16,750 for services in the Drugs Administered Other than Oral Method category, according to data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. This amount represented a 1068.1% rise compared to 2023, when related claim submissions totaled $1,434 for this service category.

Medicaid is a government health insurance initiative managed by the states and funded together by state and federal governments. The program primarily offers coverage for low-income families and individuals, older adults, children, and people with disabilities, making it a major component of the nationwide health system.

Because tax dollars fund Medicaid, shifts in billing activity at the local level reflect how each community spends public health care funds.

The “Drugs Administered Other than Oral Method” category includes services grouped by clinical care type, following standardized HCPCS and CPT categories. This analysis assigned every billing code to a single service group using consistent code prefixes and numeric ranges, ensuring services were tallied together without duplication and enabling more consistent year-to-year rankings.

Medicaid payments climbed in multiple categories, though Drugs Administered Other than Oral Method placed fifth by total payments in Mount Airy for 2024.

Within Maryland, Drugs Administered Other than Oral Method ranked 16th statewide by Medicaid spending in 2024.

Over the five years ending in 2024, Payments involving Drugs Administered Other than Oral Method in Mount Airy grew by $16,503, or 6685.5%. Major increases occurred in certain years, notably in 2021 and 2022.

Though these payments were recorded across Mount Airy, most were tied to a narrow set of ZIP codes. In 2024, ZIP code 21771 reported $16,750 connected to this category, accounting for all such Medicaid payments in the city that year.

These Medicaid expenditures, under Drugs Administered Other than Oral Method, were further focused among a small subset of specific billing codes.

By comparison, the 1068.1% jump in Mount Airy’s Drugs Administered Other than Oral Method Medicaid payments between 2024 and 2023 sharply outpaced the 14.1% rise seen across all Medicaid claim types in the city during the same timeframe.

According to the Centers for Medicare & Medicaid Services, total federal and state Medicaid expenditures reached approximately $871.7 billion in fiscal year 2023, which made up close to 18% of the nation’s health spending—an increase from roughly $613.5 billion in 2019, before the onset of the COVID-19 pandemic.

This roughly 40% growth over several years stemmed mainly from increased beneficiary enrollment and more extensive use of services throughout and following the pandemic.

Recent federal budget measures put forward during the Trump administration set substantial reductions to federal Medicaid funding and made programmatic changes. The “One Big Beautiful Bill Act,” signed in 2025, is anticipated to cut federal Medicaid outlays by more than $1 trillion over 10 years and institute provisions such as work requirements and higher cost-sharing, possibly affecting coverage and funding for select recipients. States are expected to take on a bigger share of spending, and growth in federal support may lag, though the program still serves tens of millions of Americans.

Note: HCPCS codes are listed to provide context within the service category. All totals and rankings in this report draw from standardized groupings, not individual billing codes.

The data for this article is from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The official source is available here.